Capstone Therapeutics
CAPS • OTC
Capstone Therapeutics is a publicly traded company trading on OTC, led by CEO Matthew E. Lipman.
CEOMatthew E. Lipman
Next Earnings
Upcoming earnings announcement for Capstone Therapeutics
Date
Friday, May 15, 2026 (in a month)
Timing
Before Market Open (9:35 AM New York)
Fiscal Period
Q1 2026
Earnings History
Past 2 earnings reports for Capstone Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 18, 2025 | Q3 2025 | -$0.35Est: $0.12 | -391.7% | $13.7MEst: $15.6M | -12.3% | — |
| Aug 15, 2025 | Q2 2025 | -$0.13 | — | $12.9M | — | — |